| | 65346 | | 21.07.2015 | | Amgen Switzerland AG | | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
03 | Otezla 30mg | Filmtabletten | Coated tablets (Apremilastum 30 mg) | L04AA32 | CI | 04 | Otezla 10 mg, 20 mg | 30 mg, Filmtabletten | mg (Apremilastum 10 mg) + mg (Apremilastum 20 mg) + mg (Apremilastum 30 mg) | L04AA32 | CI |
|
|